News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,268 Results
Type
Article (8016)
Company Profile (143)
Press Release (480109)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166738)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238191)
Policy (17898)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (500)
Accelerated approval (29)
ADA (18)
Adcomms (1)
Allergies (102)
Alliances (33156)
ALS (121)
Alzheimer's disease (1002)
Antibody-drug conjugate (ADC) (329)
Approvals (10477)
Artificial intelligence (370)
ASCO (160)
Autoimmune disease (241)
Automation (34)
Bankruptcy (263)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (44)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (24)
Bladder cancer (145)
Brain cancer (35)
Breast cancer (544)
Cancer (4033)
Cardiovascular disease (238)
Career advice (245)
Career pathing (1)
CAR-T (187)
CDC (2)
CDMO (30)
Celiac Disease (3)
Cell therapy (514)
Cervical cancer (36)
Clinical research (48466)
Collaboration (1362)
Commercialization (26)
Compensation (1614)
Complete response letters (36)
COVID-19 (772)
CRISPR (68)
C-suite (859)
Cystic fibrosis (89)
Data (6393)
Denatured (4)
Depression (108)
Dermatology (97)
Diabetes (382)
Diagnostics (4267)
Digital health (42)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (170)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (74022)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (237)
Events (88829)
Executive appointments (738)
Eye disease (3)
FDA (12683)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (20)
Frontotemporal dementia (25)
Funding (999)
Gene editing (132)
Generative AI (13)
Gene therapy (352)
GLP-1 (312)
Government (953)
Grass and pollen (2)
Guidances (281)
Healthcare (9396)
Hematology (95)
HIV (56)
Huntington's disease (28)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (81)
Immunology and inflammation (113)
Immuno-oncology (71)
Indications (185)
Infectious disease (979)
Inflammatory bowel disease (141)
Inflation Reduction Act (4)
Influenza (89)
Intellectual property (271)
Interviews (41)
IPO (12400)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (89)
Layoffs (59)
Legal (5195)
Licensing (50)
Liver cancer (47)
Longevity (27)
Lung cancer (580)
Lung diease (9)
Lymphoma (269)
Machine learning (30)
Management (3)
Manufacturing (620)
Marketing (21)
MASH (122)
Medical affairs (2)
Medical device (8716)
Medtech (8906)
Mergers & acquisitions (14458)
Metabolic disorders (771)
mRNA (73)
Multiple sclerosis (117)
Multispecific (3)
NASH (4)
Netherlands (3)
Neurodegenerative disease (242)
Neuropsychiatric disorders (40)
Neuroscience (1953)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (844)
Obesity (242)
Opinion (10)
Ovarian cancer (181)
Pain (194)
Pancreatic cancer (232)
Parkinson's disease (217)
Partnered (12)
Patents (525)
Patient advocacy (3)
Patient recruitment (549)
Patient selection (47)
Peanut (33)
People (41532)
Peptides (16)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15641)
Phase 2 (21657)
Phase 3 (14622)
Pipeline (8496)
Policy (18)
Postmarket research (1570)
Preclinical (6598)
Press Release (34)
Prostate cancer (209)
Psychedelics (10)
Radiopharmaceuticals (203)
Rare diseases (626)
Real estate (3025)
Recruiting (6)
Regenerative medicine (13)
Regulatory (15197)
Reports (23)
Research institute (592)
Resumes & cover letters (45)
Rett syndrome (47)
RNA editing (9)
RSV (51)
Schizophrenia (110)
Series A (177)
Series B (126)
Service/supplier (5)
Sickle cell disease (66)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2021)
Stem cells (2)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (56)
Tariffs (2)
Vaccines (353)
Venture capital (17)
Weight loss (77)
Wet AMD (3)
Women's health (100)
Date
Today (49)
Last 7 days (485)
Last 30 days (1737)
Last 365 days (19238)
2026 (15906)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34586)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (232)
Alabama (80)
Alaska (2)
Arizona (322)
Arkansas (12)
Asia (18073)
Australia (2124)
California (12974)
Canada (3374)
China (586)
Colorado (532)
Connecticut (453)
Delaware (230)
Europe (24808)
Florida (1949)
Georgia (411)
Hawaii (3)
Idaho (46)
Illinois (780)
India (62)
Indiana (335)
Iowa (19)
Japan (458)
Kansas (104)
Kentucky (33)
Louisiana (28)
Maine (27)
Maryland (1281)
Massachusetts (8475)
Michigan (322)
Minnesota (602)
Mississippi (5)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (134)
New Hampshire (61)
New Jersey (2852)
New Mexico (12)
New York (3038)
North Carolina (1374)
North Dakota (4)
Northern California (6566)
Ohio (305)
Oklahoma (15)
Oregon (17)
Pennsylvania (2415)
Puerto Rico (24)
Rhode Island (31)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5418)
Tennessee (128)
Texas (2140)
United States (42021)
Utah (396)
Vermont (1)
Virginia (168)
Washington D.C. (39)
Washington State (997)
West Virginia (1)
Wisconsin (82)
Wyoming (1)
488,268 Results for "iotamotion inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent
March 11, 2026
·
2 min read
Press Releases
iotaMotion Announces Issuance of U.S. Patent for Robotic-Assisted Cochlear Implantation Technology
June 11, 2025
·
2 min read
BioMidwest
IOTAMOTION COMPLETES $12M SERIES A RAISE TO ACCELERATE COMMERCIAL EXPANSION OF IOTASOFT® INSERTION SYSTEM
iotaMotion, Inc., a leader in developing advanced robotic-assisted systems for cochlear implant surgery, announced today the company has oversubscribed its $12 million Series A capital raise.
July 26, 2023
·
2 min read
Business
iotaMotion Inc. Appoints Mike Lobinsky as New President and Chief Executive Officer
iotaMotion Inc., a leader in developing advanced surgical systems for cochlear implant surgery, announced the appointment of Mike Lobinsky as its new President and Chief Executive Officer.
June 7, 2022
·
3 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
BioMidwest
iotaMotion Announces FDA Grants De Novo Request to Market The iotaSOFT™ Insertion System, First of Its Kind Robotic-Assisted Cochlear Implant Insertion System
iotaMotion Inc., a leader in developing advanced surgical systems for cochlear implant surgery, announced FDA granted its’ De Novo classification request to market the iotaSOFT™ insertion system.
October 5, 2021
·
3 min read
BioMidwest
iotaMotion Awarded $1.65M NIH Grant To Further Development Of Its Robotics-assisted Surgical Technology For Cochlear Implantation
iotaMotion Inc., an early-stage medical technology startup spun out of the University of Iowa’s Otolaryngology Department, announced today that the company has been awarded a $1.65M grant from the National Institutes of Health (NIH).
September 9, 2020
·
2 min read
BioMidwest
iotaMotion Submits De Novo Application To FDA For iotaSOFT™ Cochlear Implant Insertion System
iotaMotion, Inc., an early-stage medical technology startup spun out of the University of Iowa’s Otolaryngology Department, announced today that the company has filed a De Novo application seeking FDA authorization to market in the US its cochlear implant insertion system.
December 23, 2019
·
2 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
BioMidwest
iotaMotion Announces the First Cochlear Implant Surgeries Utilizing a Robotics-Assisted Cochlear Implant Insertion Device Under Abbreviated IDE Study Requirements for the iotaSOFT™ System
- iotaMotion, Inc., an early-stage medical technology startup, announced the successful completion of the world’s first two robotics-assisted cochlear implant insertions under an Abbreviated Investigational Device Exemption (IDE) using its iotaSOFT system, an investigational surgical tool currently in clinical evaluation at Univ
September 29, 2020
·
2 min read
1 of 48,827
Next
